About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Early Clinical Trial of Anti-Malarial Vaccine Proved Safe

by Mohamed Fathima S on January 12, 2019 at 10:28 AM
Font : A-A+

Early Clinical Trial of Anti-Malarial Vaccine Proved Safe

With the aim of protecting against malaria associated with pregnancy, scientists have developed a new vaccine. In an early clinical trial, the vaccine is found to be safe for pregnant women.

Malaria in pregnancy has major impacts on mother and child health. The current strategy to prevent pregnancy-associated malaria (PAM) comprises intermittent preventive treatment and use of insecticidal nets.

Advertisement


The new vaccine, developed by a team of researchers at the University of Copenhagen in Denmark, passed the test by inducing the right antibody response in the blood, according to a study published in the journal Clinical Infectious Diseases.

"It is a great milestone for us to be able to show that our vaccine is completely safe and induces the exact antibody response in the blood we want because it is the immune response that has been shown to be connected with protection from pregnancy malaria," said Morten Agertoug Nielsen, Associate Professor at University of Copenhagen.
Advertisement

For the study, the researchers examined the effect of the vaccine among 36 people in Germany.

After injecting the participants with the vaccine, the researchers were able to detect the right immune response with antibodies against the malaria parasite in the blood, and the participants showed no serious side effects.

"The next step in the process is a phase two clinical trial, which will show whether the vaccine is still safe, but also whether it can prevent disease," said Nielsen.

"Concurrently, we have developed a method for transforming the vaccine into a virus-like particle. This increases the antibody response. But the crux of the matter is whether it is sufficient for attacking all the different forms of the protein hook found in the malaria parasite," Nielsen noted.



Source: IANS
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Clinical Trials News

 New Approach Uses Nanoparticles to Repair Lymphatic Vessels
Is there a new way to treat lymphedema? Yes, swelling due to damaged lymphatic vessels can be treated using nanoparticles that can travel through the lymphatic vessels.
 Chronic Traumatic Encephalopathy (CTE) Differs in Early and Late Stage
Early and late Chronic Traumatic Encephalopathy (CTE) disease processes in the post-mortem brains were similar in some ways but dramatically different in others.
 Preventing Scar Tissue After Heart Attack With Hydrogel Therapy
Researchers have developed a new hydrogel biomaterial that adheres to heart tissue to prevent scar tissue formation after a heart attack and its consequences.
 Cannabidiol (CBD) Oil for Urinary Stones Pain Relief: Do They Work
The oil extracted from Cannabidiol (CBD) present in cannabis (marijuana) does not lower pain scores after common treatment for urinary stones.
 New Temperature-Stable Tuberculosis (TB) Vaccine is Safe and Effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Early Clinical Trial of Anti-Malarial Vaccine Proved Safe Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests